. Blocking BMP9/10-Alk1 signalling induces vascular malformations. a, Schematic of the experimental strategy to assess Alk1 deletion or BMP9/10 blockade. Arrowheads indicate intra-gastric injection of 50µg Tx at postnatal day (P3) or the intraperitoneal injections of blocking antibodies (blAB) at P3 and P4. b, Alk1 mRNA expression by qPCR using purified mouse lung endothelial cells (mLECs) isolated from P5 Tx injected mice. n=4 mice per group. Error bars: S.E.M, *P<0.05, student T test. c-e, IsolectinB4 (IB4) (red) and anti-Alk1 staining (green in single images and white in merged images) of retinal flat mounts from Ctrl (c), Alk1 iΔEC (d) and BMP9/10 blAB injected P5 mice (e). Yellow arrowheads in d and e indicate retinal AV shunts. f-h, IB4 staining (negative images of the fluorescent signal) of retinal flat mounts from Ctrl (f), Alk1 iΔEC (g) and BMP9/10 blAB injected P5 mice (h). Red arrowheads in g and h indicate retinal AV shunts and the red asterisks indicate vessel hypersprouting (middle and right panels are higher magnification of squared areas in the left panels). Scale bars: 100µm in c,d,e and 500µm in f,g,h. i-k, Quantification of AV shunt number, vascular density and number of branch points. n=14-36 retinas per group. Error bars: S.E.M, ***P<0.001, Mann-Whitney U test. a: artery in red, v: vein in blue.

